Cernostics Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
15
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$80.7M
Cernostics General Information
Description
Developer of spatial biology and AI-driven image analytics device intended to provide valuable insight to pharma clients on the pathophysiology of the disease, biomarker discovery and validation, and clinical trial support. The company's high complexity clinical reference laboratory equipment specializes in the high-dimensional analysis of tissue biopsies, providing valuable information to clinicians not available through other means, offering clients novel biological insights, better patient outcomes, and lower overall cost of care.
Contact Information
Website
www.cernostics.comCorporate Office
- 235 William Pitt Way
- Building B1
- Pittsburgh, PA 15238
- United States
Corporate Office
- 235 William Pitt Way
- Building B1
- Pittsburgh, PA 15238
- United States
Cernostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Merger/Acquisition | 03-Dec-2021 | $80.7M | Completed | Generating Revenue | ||
| 11. Later Stage VC (Series B1) | 13-Aug-2021 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series A1) | 21-Mar-2018 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series BB) | 31-Aug-2016 | Completed | Generating Revenue | |||
| 8. Grant | 01-Jul-2015 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series AA) | 08-Jun-2015 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B) | 31-Jul-2013 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jun-2012 | Completed | Startup | |||
| 4. Grant | 01-Oct-2010 | $244K | $3.06M | Completed | Startup | |
| 3. Early Stage VC (Series A) | 01-May-2010 | $2.71M | $3.06M | Completed | Startup |
Cernostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B1 | ||||||||
| Series A1 |
Cernostics Comparisons
Industry
Financing
Details
Cernostics Competitors (21)
One of Cernostics’s 21 competitors is BostonGene, a Venture Capital-Backed company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BostonGene | Venture Capital-Backed | Waltham, MA | ||||
| Tempus AI | Formerly VC-backed | Chicago, IL | ||||
| Strata Oncology | Venture Capital-Backed | Ann Arbor, MI | ||||
| Genomic Expression | Venture Capital-Backed | Beverly, MA | ||||
| Metamark Genetics | Formerly VC-backed | Waltham, MA |
Cernostics Patents
Cernostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4152001-B1 | Methods of classifying barrett's esophagus | Active | 25-Nov-2015 | ||
| ES-3056977-T3 | Methods of classifying barrett's esophagus | Active | 25-Nov-2015 | ||
| EP-3786640-B1 | Methods of detecting malignant transformation of barrett's esophagus | Active | 25-Nov-2015 | ||
| AU-2016359685-A1 | Methods of predicting progression of barrett's esophagus | Active | 25-Nov-2015 | ||
| AU-2016359685-B2 | Methods of predicting progression of barrett's esophagus | Active | 25-Nov-2015 | G01N33/5758 |
Cernostics Signals
Cernostics Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ben Franklin Technology Partners of Northeastern Pennsylvania | Venture Capital | Minority | ||
| Commonwealth Universal Research Enhancement Program | Government | |||
| Geisinger Health System | Corporation | Minority | ||
| Illumina Ventures | Venture Capital | Minority | ||
| National Cancer Institute | Government |
Cernostics FAQs
-
When was Cernostics founded?
Cernostics was founded in 2008.
-
Where is Cernostics headquartered?
Cernostics is headquartered in Pittsburgh, PA.
-
What is the size of Cernostics?
Cernostics has 15 total employees.
-
What industry is Cernostics in?
Cernostics’s primary industry is Decision/Risk Analysis.
-
Is Cernostics a private or public company?
Cernostics is a Private company.
-
What is the current valuation of Cernostics?
The current valuation of Cernostics is .
-
What is Cernostics’s current revenue?
The current revenue for Cernostics is .
-
How much funding has Cernostics raised over time?
Cernostics has raised $16.2M.
-
Who are Cernostics’s investors?
Ben Franklin Technology Partners of Northeastern Pennsylvania, Commonwealth Universal Research Enhancement Program, Geisinger Health System, Illumina Ventures, and National Cancer Institute are 5 of 10 investors who have invested in Cernostics.
-
Who are Cernostics’s competitors?
BostonGene, Tempus AI, Strata Oncology, Genomic Expression, and Metamark Genetics are some of the 21 competitors of Cernostics.
-
When was Cernostics acquired?
Cernostics was acquired on 03-Dec-2021.
-
Who acquired Cernostics?
Cernostics was acquired by Castle Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process